Main menu button

Actualités

Analysis, Kontigo: Continued growth
07 Nov 2017
Analysis, Kontigo: Continued growth
Equity Research
Analysis, Sonetel: Focus on the next step
02 Nov 2017
Analysis, Sonetel: Focus on the next step
Equity Research
Analysis, Serneke: Focus on public clients
01 Nov 2017
Analysis, Serneke: Focus on public clients
Equity Research
Analysis, GHP Specialty Care: Balancing Act
31 Oct 2017
Analysis, GHP Specialty Care: Balancing Act
Equity Research
Analysis, Lammhults: Danish operations a drag
30 Oct 2017
Analysis, Lammhults: Danish operations a drag
Equity Research
Review: Serneke Q3 2017
27 Oct 2017
Review: Serneke Q3 2017
Equity Research
Analysis, Absolicon: Solar Panels for the Future
26 Oct 2017
Analysis, Absolicon: Solar Panels for the Future
Equity Research
Analysis Multidocker: Acquisitions should decrease purchasing costs
26 Oct 2017
Analysis Multidocker: Acquisitions should decrease purchasing costs
Equity Research
Analysis Hanza: A significant better third quarter
26 Oct 2017
Analysis Hanza: A significant better third quarter
Equity Research
Analysis, Xbrane: Delivery and progress in the lab
25 Oct 2017
Analysis, Xbrane: Delivery and progress in the lab
Equity Research
Analysis, Wilson Therapeutics: Green Light for Phase III
25 Oct 2017
Analysis, Wilson Therapeutics: Green Light for Phase III
Equity Research
Analysis, myTaste: Acquisition creates value
18 Oct 2017
Analysis, myTaste: Acquisition creates value
Equity Research
Analysis, Follicum: Dawning Opportunity in Hair Growth
12 Oct 2017
Analysis, Follicum: Dawning Opportunity in Hair Growth
Equity Research
Analysis, Brighter: 10,9,8.... launch
10 Oct 2017
Analysis, Brighter: 10,9,8.... launch
Equity Research
Analysis, Maxkompetens: Undiscovered growth
04 Oct 2017
Analysis, Maxkompetens: Undiscovered growth
Equity Research
Analysis, Kopy Goldfields: Increased Resources Bode Well
02 Oct 2017
Analysis, Kopy Goldfields: Increased Resources Bode Well
Equity Research
Analysis, Pharmacolog: Refreshing capital injection
28 Sep 2017
Analysis, Pharmacolog: Refreshing capital injection
Equity Research
Comment Q1: Maxkompetens, better than expected
28 Sep 2017
Comment Q1: Maxkompetens, better than expected
Equity Research
Analysis, GHP Specialty Care: Weakness creates opportunity
26 Sep 2017
Analysis, GHP Specialty Care: Weakness creates opportunity
Equity Research
Preview, Maxkompetens Q1
26 Sep 2017
Preview, Maxkompetens Q1
Equity Research